• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[勘误] 用于卵巢癌患者的 19 个 miRNA 支持向量机分类器和 6 个 miRNA 风险评分系统。

[Corrigendum] A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.

机构信息

Department of Anesthesiology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100001, P.R. China.

出版信息

Oncol Rep. 2019 Dec;42(6):2855. doi: 10.3892/or.2019.7385. Epub 2019 Oct 23.

DOI:10.3892/or.2019.7385
PMID:31661140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6844246/
Abstract

Subsequently to the publication of this paper, the authors have realized that the affilitation address omitted the name of the university at which this research was conducted (Capital Medical University). Therefore, the author affiliations for this paper should have appeared as follows (changes are highlighted in bold): JINGWEI DONG and MINGJUN XU.Department of Anesthesiology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100001, P.R. China. The authors regret that the name of the university was not included with the paper prior to its publication, and apologize to the readers for any inconvenience caused. [the original article was published in Oncology Reports 41: 3233‑3243, 2019; DOI: 10.3892/or.2019.7108].

摘要

随后发表本文后,作者意识到所属单位地址遗漏了研究开展的大学名称(首都医科大学)。因此,本文的作者单位应为:JINGWEI DONG 和 MINGJUN XU.首都医科大学附属北京妇产医院麻醉科,北京 100001,中国。作者对文章发表前未包含大学名称表示歉意,并对给读者带来的任何不便表示歉意。[原始文章发表于 Oncology Reports 41: 3233-3243, 2019; DOI: 10.3892/or.2019.7108]。

相似文献

1
[Corrigendum] A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.[勘误] 用于卵巢癌患者的 19 个 miRNA 支持向量机分类器和 6 个 miRNA 风险评分系统。
Oncol Rep. 2019 Dec;42(6):2855. doi: 10.3892/or.2019.7385. Epub 2019 Oct 23.
2
[Corrigendum] Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse.[勘误] 盆腔器官脱垂患者子宫骶韧带的全基因组 DNA 甲基化分析。
Mol Med Rep. 2019 Mar;19(3):2458. doi: 10.3892/mmr.2019.9852. Epub 2019 Jan 11.
3
[Corrigendum] CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.[勘误] CHD1L与肝内胆管癌的不良预后相关,并促进其增殖和转移。
Oncol Rep. 2019 Oct;42(4):1631. doi: 10.3892/or.2019.7262. Epub 2019 Aug 5.
4
[Corrigendum] The role and underlying mechanisms of microRNA‑214 in Legg‑Calvé‑Perthes disease.[勘误] microRNA-214 在 Legg-Calvé-Perthes 病中的作用及潜在机制。
Mol Med Rep. 2019 Nov;20(5):4393. doi: 10.3892/mmr.2019.10648. Epub 2019 Sep 4.
5
[Corrigendum] miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.[勘误] miR-122通过抑制叉头框O3促进肾透明细胞癌的增殖和侵袭。
Int J Oncol. 2019 Apr;54(4):1496. doi: 10.3892/ijo.2019.4694. Epub 2019 Jan 23.
6
[Corrigendum] CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.勘误:CENPE 促进肺腺癌增殖,并且直接受到 FOXM1 的调控。
Int J Oncol. 2019 Dec;55(6):1397. doi: 10.3892/ijo.2019.4872. Epub 2019 Sep 6.
7
[Corrigendum] Differences in atrial fibrillation‑associated proteins between the left and right atrial appendages from patients with rheumatic mitral valve disease: A comparative proteomic analysis.[勘误] 风湿性二尖瓣疾病患者左、右心耳心房颤动相关蛋白的差异:比较蛋白质组学分析。
Mol Med Rep. 2018 Aug;18(2):2515. doi: 10.3892/mmr.2018.9218. Epub 2018 Jun 25.
8
[Corrigendum] A 44‑gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.[勘误] 用于预测透明细胞肾细胞癌预后的44基因集。
Int J Mol Med. 2019 May;43(5):2261. doi: 10.3892/ijmm.2019.4138. Epub 2019 Mar 19.
9
[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2.[勘误] MicroRNA-497 通过靶向 Bcl-2 抑制多发性骨髓瘤生长并增加硼替佐米敏感性。
Int J Mol Med. 2019 Oct;44(4):1594. doi: 10.3892/ijmm.2019.4297. Epub 2019 Aug 2.
10
[Corrigendum] MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2.[勘误] MicroRNA-137 通过靶向 EZH2 在肝癌中发挥抑制作用。
Mol Med Rep. 2018 May;17(5):7460. doi: 10.3892/mmr.2018.8785. Epub 2018 Mar 20.

引用本文的文献

1
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.HPV 感染性卵巢肿瘤患者差异 microRNA 表达分析。
Int J Mol Sci. 2024 Jan 7;25(2):762. doi: 10.3390/ijms25020762.